Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Total Debt (2019 - 2023)

Korro Bio's Total Debt history spans 5 years, with the latest figure at $11.7 million for Q1 2023.

  • For the quarter ending Q1 2023, Total Debt fell 22.22% year-over-year to $11.7 million, compared with a TTM value of $11.7 million through Mar 2023, down 22.22%, and an annual FY2022 reading of $14.2 million, down 5.55% over the prior year.
  • Total Debt for Q1 2023 was $11.7 million at Korro Bio, down from $14.2 million in the prior quarter.
  • The five-year high for Total Debt was $15.0 million in Q4 2020, with the low at $180000.0 in Q4 2019.
  • Average Total Debt over 5 years is $12.2 million, with a median of $15.0 million recorded in 2020.
  • Year-over-year, Total Debt soared 8233.33% in 2020 and then decreased 22.22% in 2023.
  • Tracing KRRO's Total Debt over 5 years: stood at $180000.0 in 2019, then soared by 8233.33% to $15.0 million in 2020, then changed by 0.0% to $15.0 million in 2021, then fell by 5.55% to $14.2 million in 2022, then fell by 17.65% to $11.7 million in 2023.
  • Per Business Quant, the three most recent readings for KRRO's Total Debt are $11.7 million (Q1 2023), $14.2 million (Q4 2022), and $15.0 million (Q3 2022).